C4 Therapeutics Q1 2026 Earnings Strong EPS Beat Highlights Cost Discipline Amid PreRevenue Stage TSHA Q1 2026 Earnings WiderthanExpected Loss as Company Continues Development Pipeline UPWK Q1 2026 Earnings EPS Smashes Estimates Stock Reacts Positively Impinj PI Q1 2026 Earnings Mixed Quarter as EPS Slightly Misses Expectations Yet Stock Gains CNM Q1 2026 Earnings EPS Surpasses Estimates by Nearly 23 Fueled by Strong Demand in Water Infrastructure LKQ Q1 2026 Earnings EPS Misses Estimates Despite Slight Stock Uptick